Evaluation of the clinical significance of HER2 amplification by chromogenic in situ hybridisation in patients with primary breast cancer.

Nadia Dandachi; Otto Dietze; Cornelia Hauser-Kronberger

Evaluation of the clinical significance of HER2 amplification by chromogenic in situ hybridisation in patients with primary breast cancer.

Nadia Dandachi
, Otto Dietze (Co-author)
, Cornelia Hauser-Kronberger (Last author)

Institute of Pathology

Research output: Contribution to journal › Original Article › peer-review

22 Citations (Web of Science)

Original language	English
Pages (from-to)	2401-2406
Journal	ANTICANCER RESEARCH
Volume	24
Issue number	4
Publication status	Published - 2004

Keywords

HER-2/NEU ONCOGENE
RISK-FACTORS
CARCINOMA
EXPRESSION
PROGNOSIS
ERBB2
CISH

Cite this

Dandachi, N., Dietze, O., & Hauser-Kronberger, C. (2004). Evaluation of the clinical significance of HER2 amplification by chromogenic in situ hybridisation in patients with primary breast cancer. ANTICANCER RESEARCH , 24(4), 2401-2406.

Dandachi, Nadia ; Dietze, Otto ; Hauser-Kronberger, Cornelia. / Evaluation of the clinical significance of HER2 amplification by chromogenic in situ hybridisation in patients with primary breast cancer. In: ANTICANCER RESEARCH 2004 ; Vol. 24, No. 4. pp. 2401-2406.

@article{b7dea132469b42e7b158de5dea811984,

title = "Evaluation of the clinical significance of HER2 amplification by chromogenic in situ hybridisation in patients with primary breast cancer.",

keywords = "HER-2/NEU ONCOGENE, RISK-FACTORS, CARCINOMA, EXPRESSION, PROGNOSIS, ERBB2, CISH",

author = "Nadia Dandachi and Otto Dietze and Cornelia Hauser-Kronberger",

year = "2004",

language = "English",

volume = "24",

pages = "2401--2406",

journal = "ANTICANCER RESEARCH ",

issn = "0250-7005",

number = "4",

}

Dandachi, N, Dietze, O & Hauser-Kronberger, C 2004, 'Evaluation of the clinical significance of HER2 amplification by chromogenic in situ hybridisation in patients with primary breast cancer.', ANTICANCER RESEARCH , vol. 24, no. 4, pp. 2401-2406.

Evaluation of the clinical significance of HER2 amplification by chromogenic in situ hybridisation in patients with primary breast cancer. / Dandachi, Nadia; Dietze, Otto (Co-author); Hauser-Kronberger, Cornelia (Last author).
In: ANTICANCER RESEARCH , Vol. 24, No. 4, 2004, p. 2401-2406.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Evaluation of the clinical significance of HER2 amplification by chromogenic in situ hybridisation in patients with primary breast cancer.

AU - Dandachi, Nadia

AU - Dietze, Otto

AU - Hauser-Kronberger, Cornelia

PY - 2004

Y1 - 2004

KW - HER-2/NEU ONCOGENE

KW - RISK-FACTORS

KW - CARCINOMA

KW - EXPRESSION

KW - PROGNOSIS

KW - ERBB2

KW - CISH

M3 - Original Article

C2 - 15330190

SN - 0250-7005

VL - 24

SP - 2401

EP - 2406

JO - ANTICANCER RESEARCH

JF - ANTICANCER RESEARCH

IS - 4

ER -

Dandachi N, Dietze O, Hauser-Kronberger C. Evaluation of the clinical significance of HER2 amplification by chromogenic in situ hybridisation in patients with primary breast cancer. ANTICANCER RESEARCH . 2004;24(4):2401-2406.